Semaglutide New Drug Combo Well-Tolerated, Leads to Weight Loss
Combining an investigational agent, cagrilintide (Novo Nordisk), with semaglutide, a glucagon-like peptide-1 (GLP-1) agonist, leads to greater weight loss than […]
A novel therapy that combines a muscarinic receptor agonist with an anticholinergic agent is associated with a greater reduction in […]weight management
‘Landmark’ Schizophrenia Drug in the Wings?